Hydreight Technologies Inc. (“Hydreight”or the “Company”)(TSXV: NURS)(OTCQB: HYDTF)(FSE: SO6), a fast-growing mobile clinical network and medical platform which ...
The use of ketamine to treat severe depression was approved in Singapore in October 2020, to be administered as a nasal spray together with oral anti-depressant therapy. Clinical trials have shown ...
Investors interested in arranging a meeting with the Company's management during the conference can register on the BIO CEO & Investor Conference website here.